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Available online 07 August 2019Halogenated heterocyclic ligands are widely used as the potent and frequently selective inhibitors of protein ki-
nases. However, the exact contribution of the hydrophobic solvation of a free ligand is rarely accounted for the
balance of interactions contributing to the free energy of ligand binding. Herein, we propose a new experimental
method based on volumetric data to estimate the hydrophobicity of a ligand. We have tested this approach for a
series of ten variously halogenated benzotriazoles, the binding afﬁnity of which to the target protein kinase CK2
was assessed with the use of thermal shift assay. According to the hierarchical clustering procedure, the excess
volume, deﬁned as the difference between the experimentally determined partial molar volume and the calcu-
lated in silicomolecular volume, was found to be distant from any commonly used hydrophobicity descriptors
of the ligand. The excess volume, however, properly predicts solute binding afﬁnity. On theway, we have proved
that the binding of halogenated benzotriazoles to the protein kinase CK2 is driven mostly by hydrophobic
interactions.
© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Hydrophobic effect has been extensively studied for over 70 years
[1–6]. It is so because of its extreme importance in a variety of physical
and biological phenomena, including protein folding or binding of low-
mass ligands. The ﬁrst microscopic theory of hydrophobic interactions
was formulated by Frank and Evans in 1945 [7]. They described the be-
havior of water molecules organized in an ice-like structure surround-
ing the apolar solute, which was further conﬁrmed with the use of
crystallography [8] and molecular dynamics [9]. In 1959, Kauzmann
proposed that the physical properties of an aqueous hydrocarbon solu-
tion can be explained by the presence of the hydration shell, in which
the water molecules are much more ordered than those in the bulk
water [10]. Following this concept, Zamyatnin attributed the difference
between the experimentally measured volume of the protein and the
value estimated by the amino acid composition to the packing effect ac-
companied by the conformational changes of amino acid residues inside
the protein with the possible contribution of solvation phenomena
[11,12], and, since then, over than a hundred of various hydropathy
scales for amino acid residues have been proposed to support the
sequence-based prediction of speciﬁc protein properties (see: Ref. [13]
for review).. This is an open access article underA strong correlation between the free energy of hydration and the
number of water molecules packed around a hydrophobic compound
was shown by Hermann [14,15], however, at that time, there was no
quantitative description of both molecular and macroscopic hydropho-
bic phenomena until Stillinger's applied Reiss' scaled particle theory
(SPT) [16] to describe the thermodynamics of hydration [17]. The alter-
native general solvophobic theory has been proposed by Sinanoglu,
who correlated the free energy of solvation with the surface tension of
the solvent and the solute solvent-accessible area [18]. Finally, Lum,
Chandler andWeeks analyzing the size-dependency of solute-water in-
teraction, showed that the free energy of solvation for small solutes is
proportional to the volume, while that for the larger ones remains pro-
portional rather to the molecular surface [19].
The analysis of the radial distribution function (RDF) for water mol-
ecules identiﬁed in 105 highest-resolution protein structures showed
that the solvation shell resembles rather liquidwater than ice, however,
the shape of the observed RDFmaxima indicated that hydratingwater is
much more stable than the bulk one [20]. This was independently con-
ﬁrmed bymolecular dynamics studies, in which properties of water sol-
vating the solutemolecule differ from those of the bulk solvent [21–24].
An increased water density determined in silico in the vicinity of the
protein [25–27] was also conﬁrmed experimentally with the use of X-
ray solution scattering data [28,29], however, for neutron scattering,
the same authors observed the opposite effect [28,29]. Infrared spectro-
scopic data demonstrated that small hydrophobic solutes make thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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that in the bulky water [30,31], while an increased population of
water molecules strongly bound to the solute is observed for proteins
[32] or amino acids [33]. All in all, it indicates that hydrophobic effect,
i.e. solute-induced changes in the organization of the solvation shell, in-
cluding both static and dynamic properties, gather the thermodynamics
of the molecule in an aqueous solvent.
Hydrophobic effect is of extreme importance in a drug design ap-
proach, especially for highly hydrophobic ligands, the binding afﬁnity
of which may be predominated by the unfavorable interactions of the
free solute with an aqueous solvent. The effective inhibitory activity de-
pends on the apparent free energy of protein-ligand interactions, the
deconvolution of which to the contributions of direct protein-ligand in-
teractions and the solvent-driven effect of desolvation (both for ligand
and the protein) is difﬁcult, and in most cases remains unresolved.
Leo, Hansh and Elkins successfully used partition coefﬁcients in octan-
1-ol/water system (LogP) as a measure of solute hydrophobicity
[34,35]. This approach has soon become fundamental, and since then
LogP data routinely support drug design procedures. However, aqueous
solubility (LogS) and pH-dependent distribution coefﬁcient (LogD) are
also commonly used. Partition coefﬁcients usually correlates with li-
gand binding afﬁnities [36,37], however, thedependency of ligand afﬁn-
ity on LogP is generally nonlinear, thus indicating an optimal drug
hydrophobicity [2].
In the case of halogenated ligands, the exact contributions of halogen
bonding, hydrophobic effect and halogen-induced changes in the solute
electronic properties to the free energy of ligand binding cannot be ex-
tracted directly from the experimental thermodynamic data. It should
be noted that, although the enthalpy of solute-solvent interaction can
be determined calorimetrically by the combination of the enthalpy of
solution and the enthalpy of sublimation, there is still no experimental
method to estimate directly the entropic contribution to the solute-
solvent interactions. It should also be stressed that, in order to improve
the preliminary steps of drug design procedures, there is a strong need
for at least a semi-quantitative method to assess these interactions.
Here, we test our former model of hydrophobic solvation, in which
the observed excess volume (β) that represents the difference between
the experimentallymeasured partialmolar volumeand the estimated in
silicomolecular volume was attributed directly to the effect of the reor-
ganization of watermolecules in the solvation shell [38–42]. This exten-
sive thermodynamic parameter was proposed as a measure of the free
energy of the reorganization of water molecules surrounding the solute
molecule. The application of the proposed model is now tested for ﬁve
rationally selected bromo-benzotriazoles and their ﬁve chloro-
analogues. The hydrophobicity of solutes was independently estimated
from RP-HPLC retention times, the values of which were proven to cor-
relate with LogP data [43]. We have also analyzed other physicochemi-
cal parameters that are routinely determined upon the early steps of
drug design procedure (pKa, LogCw, LogP, LogS).
All tested ligands, which are the derivatives of the ﬁrst-reported
low-mass ATP-competitive inhibitor of protein kinase CK2, 4,5,6,7-
tetrabromo-1H-benzotriazole [44], are expected to bind at the ATP-
binding site of the catalytic domain of protein kinase CK2 (CK2α), so
in this way we have assessed the applicability of various methods
confronting the thermodynamic parameters determined for free ligands
with their binding afﬁnities deduced from the thermal shift assay.
2. Material and methods
2.1. General procedure for synthesis chloro-benzotriazoles
Commercially available chemicals were of reagent grade and used as
received. 3-chlorobenzene-1,2-diamine (95%)was purchased from abcr
(Karlsruhe, Germany), 4-chlorobenzene-1,2-diamine (97%) and 3,5-di-
chlorobenzene-1,2-diamine (97%) were purchased from Sigma Aldrich
(Munich, Germany), 4,5-dichlorobenzene-1,2-diamine (95%) waspurchased from Fluorochem (Hadﬁeld, UK). All bromo-substituted
benzotriazoles were synthesized according to the previously used
methods [45,46]. 4,5,6,7-Tetrachloro-1H-benzotriazolewas synthesized
according to literature procedure [47].
Melting points (uncorrected) were determined in open capillary
tubes, using a Büchi B504 apparatus. The reaction progress was moni-
tored with the use of thin-layer chromatography (TLC) analysis using
silica gel plates (Kieselgel, 60F254, E. Merck, Darmstadt, Germany). Col-
umn chromatography was performed on Silica Gel 60 M
(0.040–0.063 mm, E. Merck, Darmstadt, Germany). High-resolution
mass spectra were recorded on an LTQ Orbitrap Velos instrument
(Thermo Scientiﬁc). NMR spectra were recorded in DMSO d6; signal as-
signment for the chlorinated benzotriazoles based on the data already
published for bromo-benzotriazoles [45,46,48]. The purity of all studied
compounds was controlled with the use of HPLC twice: in isocratic con-
ditions (2: 1 methanol: 20 mM ammonium formate, (AF) pH 6.5), and
with the linear gradient of 20 mM AF pH 6.5 × 65–95% aq. MeOH over
30 min at a ﬂow rate of 0.7 mL/min.
A solution of 10 mmol of the appropriate benzene-1,2-diamine in
3.5 mL of acetic acid (AcOH) and 1 mL of water was cooled to 0–5 °C,
followed by the addition of 15 mmol of sodium nitrite in 2 mL of
water. The mixture was stirred for 2 h at room temperature. After
the completion of the reaction, a solvent was evaporated and the res-
idue was co-evaporated with toluene (3 × 20mL). The crude product
was partitioned between water (20 mL) and ethyl acetate (20 mL),
the organic phase was washed with the saturated solution of sodium
hydrogen carbonate and dried over magnesium sulfate (MgSO4). The
products were puriﬁed by crystallization from nitromethane and/or
by column chromatography on silica gel using a chloroform – meth-
anol 97:3–95:5 v/v mixture as eluent. Reaction products were ana-
lyzed by use of mass-spectrometry (Waters Q-TOF Premier Mass
Spectrometer) and NMR spectroscopy (Varian INOVA 500 Spectrom-
eter, see Supp. Fig. 1). Purity of the products was assessed using in-
ternal standard quantitative NMR method (qNMR) [49]. It should
be noted that the formal qNMR-derived purity determined for 4-
BrBt, 4-ClBt, 5,6-Cl2Bt and 5,6-Br2Bt increased signiﬁcantly upon ad-
dition a small amount of water to the DMSO solution, which in-
creased proton exchange rates. This observation indicates that the
nuclear relaxation process accompanying protomeric equilibrium
(generally N1-H and N3-H forms predominates) signiﬁcantly con-
tribute to the obtained NMR spectra, the best proof of which is the
strong broadening of the H-7 resonance line in 4-BrBt and 4-ClBt
(Supp. Fig. 1A,B).
4-Chloro-1H-benzotriazole (4-ClBt): yield 550 mg (24%);
mp. 170.6–172.1 °C (lit. 168.5–169.5 °C) [50]; HRMS (ESI): m/z [M
+ H]+ calc. For C6H5ClN3: 154.01665, 156.01370 found: 154.01665,
156.01362; 1H NMR 500 MHz (DMSO d6) δ [ppm]: 7.87 (bs, 1H, H-7);
7.50–7.57 (m, 2H, H-5,H-6: 7.56; assigned as ad, 1H, H-5, J = 7.4 Hz;
7.51 and at, 1H, H-6, J= 7.4 Hz); qNMR purity (PqNMR): 89.3%; (Supp.
Fig. 1B).
5-Chloro-1H-benzotriazole (5-ClBt): yield 400 mg (32%);
mp. 158.7–159.8 °C (lit. 156–157 °C) [46,51]; HRMS (ESI): m/z [M
+ H]+ calc. for C6H5ClN3: 154.01665, 156.01370 found: 154.01665,
156.01363; 1H NMR 500 MHz (DMSO d6) δ [ppm]: 8.05 (s, 1H, H-4);
7.99 (d, 1H, H-7, J = 8.8 Hz); 7.50 (dd, 1H, H-6, J1 = 7.5 Hz, J2 =
1.9 Hz); PqNMR: 93.9%; (Supp. Fig. 1D).
4,6-Dichloro-1H-benzotriazole (4,6-Cl2Bt): yield 773 mg (49%); mp.
246–247.7 °C (lit. 245.5–246.5 °C) [52]; HRMS (ESI):m/z [M+H]+ calc.
for C6H4Cl2N3: 187.97768; 189.97473 found: 187.97748; 189.97446; 1H
NMR 500 MHz (DMSO d6) δ [ppm]: 8.01 (s, 1H, H-7); 7.67 (d, 1H, H-5,
J= 1.4 Hz); PqNMR: 95.3%; (Supp. Fig. 1F).
5,6-Dichloro-1H-benzotriazole (5,6-Cl2Bt): yield 690 mg (32%);
mp. 263.5–266.5 °C (lit. 264–266 °C); HRMS (ESI): [48,53] m/z [M
+ H]+ calc. for C6H4Cl2N3: 187.97768; 189.97473 found: 187.97752;
189.97451; 1H NMR 500 MHz (DMSO d6) δ [ppm]: 8.31 (s, 2H, H-4,H-
7); PqNMR: 84.0%; (Supp. Fig. 1H).
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mp. 258.4–261.5 °C (lit. 256–260 °C) [47,48] HRMS (ESI): m/z [M
+ H]+ calc. for C6H2Cl4N3: 255.89973, 257.89678, 259.89383 found:
255.89938, 257.89645, 259.89348;
4-Bromo-1H-benzotriazole (4-BrBt): 1H NMR500MHz (DMSO d6) δ
[ppm]: 7.91 (d, 1H, H-7, J= 7.9 Hz); 7.71 (d, 1H, H-5, J= 7.4 Hz); 7.45
(t, 1H, H-6, J= 7.9 Hz); PqNMR: 96.7%; (Supp. Fig. 1A).
5-Bromo-1H-benzotriazole (5-BrBt): 1H NMR500MHz (DMSO d6) δ
[ppm]: 8.20 (s, 1H, H-4); 7.93 (d, 1H, H-7, J=8.7 Hz); 7.62 (dd, 1H, H-6,
J1 = 8.8 Hz, J2 = 1.8 Hz); PqNMR: 99.2%; (Supp. Fig. 1C).
4,6-Dibromo-1H-benzotriazole (4,6-Br2Bt): 1H NMR 500 MHz
(DMSO d6) δ [ppm]: 8.01 (d, 1H, H-7); 7.67 (d, 1H, H-5, J = 1.5 Hz);
PqNMR: 99.5%; (Supp. Fig. 1E).
5,6-Dibromo-1H-benzotriazole (5,6-Br2Bt): 1H NMR 500 MHz
(DMSO d6) δ [ppm]: 8.45 (s, 2H, H-4,H-7); PqNMR: 91.6%; (Supp. Fig. 1G).
3. Experimental
3.1. Solute properties in aqueous medium
3.1.1. pKa determination
All ligands were titrated in the pH range of 3.5–10.5. Changes in ab-
sorption spectra recorded in the range 200–600 nm (Perkin Elmer
Lambda 25 UV–vis spectrometer) were further analyzed globally ac-
cording to the Henderson-Hasselbach formula, as proposed previously
[45]; albeit the appropriate numerical model was implemented in Ori-
gin (www.originlab.com).
3.1.2. Aqueous solubility
The solubility of each benzotriazole derivative was determined at
pH 8 in 25 mM Tris-HCl buffered solution. The suspensions, shaken at
25 °C for 72 h using Eppendorf Thermomixer Comfort,were then centri-
fuged and the solute concentration in the supernatant was determined
from the UV–vis spectra of diluted solution (200–600 nm).
3.1.3. Chromatographic hydrophobicity index
Reverse phase HPLC analysis (RP-HPLC) was performed using a
Knauer dual pump system equipped with a multi-channel UV spectro-
photometer based on a diode array technology detector managed by
ClarityChrom controller version 6.1.0.130. Separations were performed
on a Waters Nova-Pak® C18, 60 Å, 4 μm, 4.6 × 250 mm, cartridge col-
umn, at a ﬂow rate of 0.6 mL × min−1, at 25 °C (working pressure
~12 MPa), with detection at 280 nm. An isocratic mobile phase com-
posed of methanol and 20 mM aqueous ammonium formate (pH 6.5
or 8.0) in proportion either 2:1 or 7:3 (v:v) was applied. RP-HPLC-
derived retention times, Tret, were then converted to log(τ) scale ac-
cording to the relation τ = (Tret − T0) / T0, in which the retention
time of the unretained solvent, T0, was estimated to 300 s.
3.2. QM methods
Ab initio calculations were done for the monoanionic form of all ha-
logenated benzotriazoles, and for the two asymmetric protonation
states of their neutral form using Fireﬂy version 8.2 (Alex A. Granovsky,
Fireﬂy version 8, http://classic.chem.msu.su/gran/ﬁreﬂy/ index.html),
the code of which was partially based on GAMSESS US [54]. The initial
coordinates of nine chloro-derivatives, adopted from those of their
bromo-analogues by the adjustment of C-Cl distance to 1.73 Å,were op-
timized using the DFT B3LYP functional with 6-31G(d,p) basis set. The
contribution of solute-solvent interaction was estimated using the po-
larizable continuum model (PCM) [55]. The dissociation of the triazole
proton, ΔGdiss = Gneutral− Gmonoanio− Ghydr(H+), and the solvation
of the anionic form, ΔGint, were analyzed in the terms of difference in
the free energy with Ghydr(H+) taken as−262.3 kcal/mol [56]. Molecu-
lar volume (Vmol) and the volume of the solvation shell (Vsolv) werecalculated using the algorithm of tessellation originally implemented
in the GEPOL [57].
3.3. Physicochemical ADME parameters
The larger set of parameterswasdeterminedwith SwissAdme server
[58]. The matrix of squared pairwise Pearson's correlation coefﬁcients
calculated for each pair of parameters was subjected to hierarchical
cluster analysis according to Ward's minimum variance method [59]
implemented in R package [60] (www.R-project.org).
3.4. Thermal shift assay
Allmeasurementswere carried outwith VarianCary Eclipse spectro-
ﬂuorometer equipped with a variable-temperature four-cell holder
dedicated for 10 mm path length cuvettes. Protein emission was moni-
tored at 335 nm (excitation at 280 nm) in temperature range of 20 to 80
°Cwith 1 °C/minheating rate. The catalytic subunit of humanprotein ki-
nase CK2 (hCK2α),was expressed and puriﬁed according to themethod
described previously [61]. The protein sample was diluted with 25 mM
Tris-HCl (pH 8, 0.5MNaCl) to the required concentration of 0.25 μM. All
ligands, initially dissolved in DMSO, were added to the protein solution
in 10 fold excess (2.5 μM), and the resulting solutionswere further sup-
plementedwithDMSO to keep itsﬁnal concentration constant (2%). The
temperature-induced changes of protein ﬂuorescence, F(T), were ana-
lyzed according to the model of two-state transition [62], implemented
in Origin (www.origin.com) in the form:
F Tð Þ ¼ punf  Funf Tð Þ þ 1−punf
 
 Ffold Tð Þpunf
¼ 1þ exp ΔG=RTð Þf g−1ΔG ¼ ΔHunf þ ΔCp  T−Tmð Þ þ T
 ΔSunf þ ΔCp  ln T=Tmð ÞΔHunf
þ Tm  ΔSunf
¼ 0 ð1Þ
where Funf and Ffold are the low- and high-temperature linear asymp-
totes of F(T), respectively. For each experiment these asymptotes were
individuallyﬁtted,while the other thermodynamic parameters:melting
temperature (Tm), the enthalpy of unfolding (ΔHunf) and heat capacity
change upon denaturation (ΔCp) were optimized globally for all data
collected for a given ligand (Supp. Fig. 2).
3.5. Density measurements
Partial Molar Volumes were estimated on the basis of the experi-
mentally determined concentration-density dependency of the aque-
ous solutions of compounds in 50 mM phosphate buffer at pH 11.
Such a high pH value was set, because the limited solubility of some ha-
logenated bezotriazoles at pH 8 (e.g. TBBt or 5,6-Br2Bt) precluded pre-
cise measurements. For each compound the exact densities for a series
of the dilutions of the stock solution were measured on high-precision
density meter Anton Paar DMA 5000 M, in which the U-shaped tube
ﬁlled with a sample solution is electronically excited to oscillate. Ac-
cording to supplier recommendation, the system was daily checked
for empty tube (i.e. scaled on the air density), and for the reference liq-
uid density standard sample of Anton Paar's certiﬁed ultra-pure water.
All samples were degassed before measurement.
1. Theory
According to the iceberg hypothesis of Frank and Evans, hydropho-
bic solutes are expected to order surrounding water molecules [7].
Thus, the difference between the experimentally determined partial
molar volume and the estimated in-silico molecular volume reﬂects
the net effect of the solute-induced reorganization of the solvation
shell [38–42]. Our previous studies clearly demonstrated that for ex-
tremely non-polar solutes the apparent density of the solvation shell
Table 1
Thermodynamic parameters calculated (ΔGioniz,ΔGint, Vmol) and determined experimentally (V20, β, pKa, log(Cw) and log(τ)) for halogenated benzotriazoles in aqueous solution, and tem-
perature of thermal denaturation of their complexes with hCK2α (Tm).
Subst. pattern ΔGioniz ΔGint Vmol V20 β pKa log(Cw) log(τ) Tm
[kcal/mol] [cm3/mol] [M] pH = 8 [°C]
apo – – – – – – – 47.9 ± 0.1
CHHH 35.4 −55.3 71.4 127.4 ± 0.4 56.0 ± 0.4 7.17 −1.98 −0.71 47.6 ± 0.2
HCHH 37.4 −52.7 71.4 132.3 ± 0.6 60.9 ± 0.6 7.73 −2.17 −0.49 48.5 ± 0.1
CHCH 33.3 −47.9 80.7 143.7 ± 0.5 63.0 ± 0.5 6.19 −2.57 −0.49 49.6 ± 0.1
HCCH 35.3 −47.4 80.6 134.4 ± 0.6 53.8 ± 0.6 6.83 −3.33 −0.37 51.4 ± 0.1
CCCC 29.1 −40.7 99.1 166.7 ± 0.5 67.6 ± 0.5 5.16 −4.64 −0.07 50.2 ± 0.1
BHHH 36.1 −54.8 74.9 139.0 ± 0.3 64.1 ± 0.3 7.08 −2.41 −0.65 48.9 ± 0.2
HBHH 38.2 −51.7 75.1 133.7 ± 0.6 58.6 ± 0.6 7.55 −2.56 −0.40 48.7 ± 0.1
BHBH 34.1 −47.1 87.9 151.7 ± 0.6 63.8 ± 0.6 6.38 −3.63 −0.37 50.1 ± 0.1
HBBH 36.4 −46.4 87.7 147.3 ± 0.5 59.6 ± 0.5 6.93 −3.64 −0.29 53.1 ± 0.1
BBBB 30.9 −40.8 113.2 192.0 ± 1.5 78.8 ± 1.5 5.10 −3.66 −0.00 54.1 ± 0.1
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(β) may be regarded as a measure of solute hydrophobicity [40,42].
Here we tested the latter hypothesis on biochemically relevant ligands
using more sensitive apparatus and applying the improved method of
the analysis of volumetric data.
2. Calculations
The standard analysis of density data based on the apparent molar
volume [63], Vφ, (Eq. 2) was found inapplicable due to the limited aque-
ous solubility of all studied highly hydrophobic compounds and the
hardly reproducible composition of buffered solution constituing a
‘pure solvent’.
Vϕ ¼ 10
3
mρρ0
ρ0−ρð Þ þ
M
ρ
ð2Þ
where m is the molal concentration of the solute (mol/kg), M is the
molar mass, and ρ and ρ0 are the density of the solution and the ‘pure
solvent‘, respectively. However, partial molar volume, V20, can be esti-
mated directly from the density data:
V02 ¼ Vm→0ϕ ¼
M
ρ0
−
103
ρ20
 ∂ρ
∂m
j
m¼0
ð3ÞScheme 1. Chemical structures of thwhere ρo and ∂ρ/∂m are the intercept and slope in the linear approxi-
mation of ρ(m). This approach includes additional auto-correction for
the density of the ‘pure solvent‘, which cannot be sufﬁciently
reproduced in independent buffer preparations. The numerical model
based on Eq. (3) was implemented in Origin (www.origin.com).
We have extensively tested the reproducibility of measurements
and sensitivity to independent buffer preparations (Supp. Fig. 3A, and
Supp. Table 1) and found that the global analysis at 3 close temperatures
improves precision when linear relation V20(T) is assumed (see Supp.
Fig. 3B and Supp. Table 1).
The model was also ﬁtted independently to each dataset, and the
resulting set of partial molar volume values did not differ signiﬁcantly
from the value obtained by global ﬁtting to all experiments. This latter
approach resulted, however, in the reduced uncertainty (standard devi-
ation) of the estimated V20.
4. Results and discussion
We introduced new extensive thermodynamic parameter, β, which
can be interpreted as ameasure of solvation free energy and thus can be
used to determine effective compounds' hydrophobicity. We have
tested our model with the rationally chosen halogenated derivatives
of benzotriazole, which are expected to be the competitive inhibitors
of the human protein kinase CK2. The particular patterns of halogen
substitution (see Scheme 1) were selected to affect signiﬁcantlye compounds used in the study.
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be stressed that the halogenation of any solute molecule generally in-
creases its hydrophobicity. To overcome this problem, in parallel we
studied chlorinated derivatives that stood the reference set for the se-
ries of brominated benzotriazoles. For the latter ones, we have already
determined physicochemical [45], biochemical [64] and thermody-
namic [61,65,66] parameters describing their interaction with the cata-
lytic subunit of human protein kinase CK2 (hCK2α). Chlorinated
benzotriazoles should display similar physicochemical properties, how-
ever they are less hydrophobic than their brominated counterparts and
hence their solubility in the aqueous solution should be increased. They
are also expected to display lower propensities for the formation of hal-
ogen bonds in protein–ligand systems [67–70].
4.1. QM calculations
QM-calculations proved that electronic properties for both series of
halogenated benzotriazoles are similar in aqueousmedium (Table 1) in-
cluding the free energy for the dissociation of the triazole proton
(Fig. 1A), and the free energy of solute-solvent interactions for both
neutral (not shown) and monoanionic (Fig. 1B) forms, both of which
are highly correlated for the pairs of the corresponding isomeric forms
of chloro- and bromo-benzotriazoles.
Following the above correlations, two mono-substituted (4-ClBt, 5-
ClBt), two bi-substituted (4,6-Cl2Bt, 5,6-Cl2Bt) and per-chlorinated
TCBt, together with their ﬁve bromo-analogues (Scheme 1), were se-
lected for further biophysical and biochemical studies.
Three of these chlorinated benzotriazoles are the analogues of the ef-
ﬁcient bromo-benzotriazole ligands of hCK2α (5-BrBt, 5,6-Br2Bt and
TBBt) [66], while the two remaining counterparts (4-BrBt and 4,6-
Br2Bt) were found substantially less active [61].
4.2. Physicochemical properties in solution
Eleven in silico determined ADME parameters (MW - molecular
weight; MR - molar refraction index, iLOGP, XLOGP3, WLOGP, MLOGP,
Silicos-IT LogP; Consensus LogP; ESOL LogS; Ali LogS; and Silicos-IT
LogSw) together with molecular volume (Vmol) were analyzed for
the set of nine chloro- and nine bromo- benzotriazole derivatives.
Most of these parameters, summarized in Supp. Table 2, were found ex-
tremely correlated (Supp. Fig. 4). Ten of them cluster into two groups
consisting of ESOL LogS, MR, Vmol and Silicos-IT LogSw, and Silicos-IT,
LogP, Ali LogS, XlogP3, MLOGP, WLOGP and Consensus LogP, respec-
tively, while iLOGP and MW are less correlated with the other ones. It
should be also noted that iLOGP [71] is the only parameter that differen-
tiates between isomers (Fig. 1C), which, however, substantially differ
both in their physicochemical properties in the aqueous solution [45]
and in afﬁnity towards hCK2α [61] (Table 1).
The pKa values for the dissociation of the triazole proton has already
been determined for all the possible bromination patterns of the ben-
zene ring of benzotriazoles [45]. Importantly, the values determined
for the ﬁve selected chlorine derivatives (Table 1) are highly correlated
with those for the corresponding bromo-analogues (Fig. 1D). This
clearly conﬁrms that the electronic effect associated with the replace-
ment of all the bromine atomsof the bromo-benzotriazolewith chlorine
remains uniform for the whole set of analyzed compounds. In addition,
experimental Log(Cw) is reasonably correlated with estimated in silico
LogS (R2 = 0.77 for Silicos-IT Log Sw; 0.95 when TBBt was excluded,
Fig. 1F). So, a major disagreement involving the experimental solubility
of TBBt must result from intensive (nano)aggregation, the existence of
which, conﬁrmed with the use of DLS technique [66], enhances appar-
ent solubility.
The correspondence of in silico and experimentally derived parame-
ters conﬁrms that all tested benzotriazole derivatives may be regarded
representative for testing application of thermodynamic parameters,
to characterize the physicochemical properties of other compounds.4.3. Density measurements – partial molar volumes of the monoanionic
form of variously halogenated benzotriazoles
Experimental data was collected for benzotriazole, its ﬁve chloro-
and ﬁve equivalent bromo-derivatives at 20, 25 and 30 °C (Supp.
Table 3). All themeasurementswere carried out in the aqueous solution
buffered at pH 11, so volumetric data concern the monoanionic form of
the solute. Such a high pHwas applied to enhance solubility and to pre-
vent possible aggregation, the existence of which at themoderate pH of
8 has been already proven for TBBt [66]. According to F-test [72], the
concentration-density relation was found linear for all compounds, so
Eq. (3) was used to estimate V20. The intercept, which corresponds to
the density of the ‘pure solvent’ (buffer) slightly differs between partic-
ular samples, thus clearly exemplifying the advantages of the proposed
method of data analysis (see Supp. Table 1 and Supp. Fig. 3 for details).
As expected, partial molar volume generally varies with temperature,
albeit the ﬁrst-order linear approximation was always found sufﬁcient
by F-test. Finally, V20 and ∂V20/∂T were optimized globally for each com-
pound, while ‘poor solvent’ density was ﬁtted individually for each
dataset.
For each compound the expected molar volume (Vmol) and the vol-
ume of the solvation shell (Vsolv) were estimated in silico on the basis of
its modeled structure and atomic radii (see QM calculations). We inter-
pret the difference between measured partial molar volume (V20) and
the expected molecular volume (Vmol) as the result of speciﬁc solute-
solvent interactions. This difference mostly reﬂects solute-induced var-
iation in the average organization of water molecules that solvate a hy-
drophobic species [38,39]. This excess volume, β = V20 − Vmol, is the
extensive parameter, which can thus be interpreted as ameasure of sol-
vation free energy, while α=− β/Vsolv describes the apparent solute-
induced change in the solvent density within the solvation shell consti-
tuting apparent measure of solute polarity [40,41].
As expected, partialmolar volume (V20) increaseswith the number of
halogen atoms attached to the benzene ring of benzotriazole, and is
strongly correlated with calculated in silicomolecular volume, Vmol (R2
= 0.98, Fig. 2A).
However, the excess volume, β, is substantially less correlated (R2=
0.83, Fig. 2B), whichmakes it possible to support the standard QSAR ap-
proach. It should also be mentioned that β is always larger for bromo-
benzotriazoles than for their chloro-analogues, thus, clearly conﬁrming
that bromine is much more hydrophobic than chlorine.
4.4. Chromatographic hydrophobicity index
HPLC technique becomes fast and efﬁcient alternative to the stan-
dard LogD determination in octan-1-ol/water system [73–75]. In order
to assess the applicability of the method to so hydrophobic ligands we
have tested mobile phase using two methanol:buffer ratios (2:1 and
7:3 v/v). RP-HPLC runswere performed at pH 8 to estimate solute prop-
erties in the same conditions, at which other measurements were done.
The same experiments were repeated at pH 6.5 to monitor the possible
contribution of solute ionic state to the apparent hydrophobicity. To
asses reproducibility, two additional runs were done at pH 6.5 (2:1 v:
v) using the other columnof the same type. Retention times determined
at a given pH are strongly correlated (R2 N 0.98),while those obtained at
different pH are clearly less, but still signiﬁcantly correlated (R2 =
0.80–0.86, see Fig. 4 below). All HPLC-derived data are summarized in
Supp. Table 4.
4.5. Thermal shift assay
We have also tested the applicability of the excess volume (β) in the
analysis of the hydrophobic contribution to the stability of protein-
ligand complexes. The latter was assessed as a temperature shift in the
ﬂuorescence recorded upon the thermal unfolding of the appropriate
complex (Thermal Shift Assay). In the case of small rigid ligands any
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Fig. 1. Correspondence of the free energy for the dissociation of the triazole proton of selected brominated benzotriazoles with their chlorinated counter-partners (A), energy of solute-
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indicative of the binding – the stronger ligand binding to the protein the
higher is the middle-point temperature of the transition (Tm). For the
apo form of hCK2α, and for its complexes with halogenated
benzotriazoles, all the experimental thermal denaturation curves
agree with the simplest model of two-state transition (Supp. Fig. 2). Inthe case of six ligands (4,6-Cl2Bt, 5,6-Cl2Bt, TCBt, 4,6-Br2Bt, 5,6-Br2Bt,
TBBt), the thermal stability of their complexes signiﬁcantly exceeds
that of the apo form of hCK2α (α b 10−6), while the four remaining
ones do not affect protein unfolding, thus indicating that they virtually
do not bind to hCK2α at the tested concentration (Table 1). Contrary
to QM-derived and physicochemical parameters, no signiﬁcant Tm
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Fig. 2. Correlation of estimated in silico molecular volume, Vmol, with experimentally determined partial molar volume, V20 (A) and the resulting excess volume, β (B).
7A. Szymaniec-Rutkowska et al. / Journal of Molecular Liquids 293 (2019) 111527correspondence between chloro- and bromo-benzotriazoles is observed
(Fig. 1E). This clearly indicates that the replacement of bromine with
chlorine individually affects different complexes. Since a balance of elec-
trostatic and hydrophobic interactions was found to contribute pre-
dominately to the binding of bromo-benzotriazoles to hCK2α [61,65],
only moderate trend for Br replacement with Cl could be observed.
According to our understanding of accessible thermodynamic data
[61,66], we expected a general monotonic relation between β for the
free solute and denaturation temperature of the protein-ligand complex
(Tm). So, the greater hydrophobicity of the ligand, the stronger binding
to the protein and the higher temperature at which the complex un-
folds. In fact, the relation Tm(β) was found almost linear (Fig. 3A). The
uniform trend observed for eight ligands is indicative of a common pat-
tern of interactions driving the formation of the protein-ligand complex,
predominated by the hydrophobicity of the free solute. Consequently,
the complexes of the two remaining ligands (5,6-Br2Bt, and 5,6-Cl2Bt),
the data ofwhich substantially deviates from the correlation line, are in-
dicative of an alternative pattern of interactionswithin the complex that
additionally stabilize ligand-bound state. At themoment, it could be hy-
pothesized that the complexes of these two ligands are stabilized by in-
termolecular halogen bond(s) formed with the hinge region of hCK2α,
as it was observed for the numerous halogenated ligands bound by a
protein kinase [68,69,76–78].
Interestingly, the predictive power of the excess volume was found
close to that of iLOGP, and signiﬁcantly stronger than that of any other
parameter (Fig. 3). We have also analyzed correlation matrix deter-
mined for 25 parameters describing both in silico and the experimen-
tally derived properties of ten analyzed halogenated benzotriazoles
(Fig. 4).
All in-silico determined LogS/LogP values are clustered together,
however they are also correlated with molecular volume (Vmol),
which, according to LCW theory, is a measure of hydrophobic solvation
[19], and an experimentally determined partial molar volume (V20),
which should be considered as the experimental equivalent of
Vmol. Experimental pKa for the dissociation of the triazole proton is clus-
tered with QM-derived free energy for the dissociation of that proton,
but also with the QM-derived free energy of solvation. Interestingly,
all these three parameters cluster with the excess volume, β, thus
clearly pointing that hydrophobic interactions are predominately af-
fected by the ionic state of the solute molecule.
As expected, HPLC-derived hydrophobicity data are clustered to-
gether, however, all these parameters are also substantially correlated
with the experimental LogCw and QM-derived free energy of solute-
solvent interaction, ΔGint.The last two parameters: molecular weight (MW) and iLOGP are
clustered together with the denaturation temperature of protein-
ligand complexes (Tm), which is a measure of ligand afﬁnity. Tm also re-
mains relatively close to LogCw and HPLC-derived hydrophobicity. Alto-
gether, it clearly conﬁrms that the binding of halogenated
benzotriazoles is mostly driven by hydrophobic interactions.
In this view, the complexes of 5,6-Br2Bt, and 5,6-Cl2Bt, both of which
disagree with a general trend observed for Tm as a function of β
(Fig. 3A), experimental LogCw (Fig. 3B), chromatographic hydrophobic-
ity index (Fig. 3C), andQM-derivedΔGint (Fig. 3D),must be stabilized by
another type of interactions. In fact, we identiﬁed two alternative loca-
tions of 5,6-Br2Bt in the recently solved structure of its complex with
Z. mays CK2α (5TS8, Fig. 5A), while no such effect is observed for TBBt
bound to the same protein (1 J91, Fig. 5B) [79].
The two poses of 5,6-Br2Bt reﬂect competition between halogen
bonds formed with carbonyl oxygen atoms of Glu114 and Val116 lo-
cated in the hinge region (red arrows in Fig. 5A) and electrostatic inter-
actionswith the salt bridge formed by Lys68 andGlu81 (magenta arrow
in Fig. 5A), while TBBt interacts only with Lys68/Glu81 (magenta arrow
in Fig. 5B). Alternative ligand poses identiﬁed in the case of 5,6-Br2Bt are
commonly observed in already resolved complexes of a protein kinase
with a halogenated ligand [69]. In this context, the increased stability
observed for hCK2α complexwith 5,6-Br2Btmay be regarded indicative
of the halogen bonding. It must be, however, noted that the sequence of
Z. mays CK2α differs from that of hCK2α, so the thermodynamic obser-
vations cannot be directly related to the structural data. Nonetheless,
the coexistence of two alternative poses for 5,6-Br2Bt indicates that, at
least for Z. mays CK2α, the thermodynamic contribution of two halogen
bonds is comparable to that of electrostatic interactions, which how-
ever, predominate for TBBt.
5. Conclusions
The proposed new thermodynamic parameter β (excess volume)
correlates with the temperature of denaturation of the protein-
ligand complex (Tm), which is the commonly accepted indicator of
the strength of protein-ligand interaction. However, Tm is relatively
independent of the standard set of in silico derived physicochemical
parameters that are routinely used in drug design approach. For such
hydrophobic ligands, an uncontrolled spontaneous solute (nano)ag-
gregation [66] precludes the application of apparent ligand solubility
as a measure of hydrophobicity. The same may to some extent con-
cern experimental partition coefﬁcients (LogP and LogD). So, we
conclude that the excess volume may constitute an alternative to
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8 A. Szymaniec-Rutkowska et al. / Journal of Molecular Liquids 293 (2019) 111527quantifying the hydrophobicity of the solute, and also to estimating
the contribution of hydrophobic effect to overall free energy for li-
gand binding. Finally, the large positive excess volumes determined
for all studied compounds indicate that the structure of water in
the solvation shell is disrupted and, in agreement with the iceberg
concept of Frank and Evans, its average density is signiﬁcantly
lower than that of the bulky solvent. The determined values of excessvolume can therefore be directly used to test the quality of various
models of aqueous solvents.
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Fig. 4. Correlation matrix for the physicochemical parameters determined both in silico and experimentally (denaturation temperature of hCK2α complex with a given ligand, Tm, partial
molar volume, V20, exces volume,β, aqueous solubility at pH8, LogCw,HPLC-derived hydrophobocity, log(τ), and pK for dissociation of the triazole proton. Hierarchical clusteringwas done
for the matrix of variance using Ward's minimum variance method.
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Fig. 5. Binding modes observed for complexes of the catalytic subunit of Z. mays protein
kinase CK2 with 5,6-Br2Bt (A, 5TS8) and TBBt (B, 1 J91). Residues located in the hinge
region that often accepts halogen bonds (Glu114 and Val116), together with Lys68 and
Glu81 forming salt bridge are denoted. Red arrows point halogen bonds, while magenta
ones denote electrostatic interactions with Lys68/Glu81 that is most commonly
observed in complexes of benzotriazole derivatives with protein kinases.
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